Article
FDA News
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
(EyePod) From idea to impact: Navigating ophthalmic innovation
ForSight Robotics completes $125M Series B funding to address global surgeon shortage
Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE